Efficacy and Safety of Tangshen Formula on Patients with Type 2 Diabetic Kidney Disease: A Multicenter Double-Blinded Randomized Placebo-Controlled Trial

BACKGROUND: Persons with diabetes are at high risk of developing diabetic kidney disease (DKD), which is associated with high morbidity and mortality. Current drug therapies for DKD, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), are not entirely s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ping, Chen, Yiping, Liu, Jianping, Hong, Jing, Deng, Yueyi, Yang, Fang, Jin, Xiuping, Gao, Jing, Li, Jing, Fang, Hui, Liu, Geling, Shi, Liping, Du, Jinhang, Li, Yang, Yan, Meihua, Wen, Yumin, Yang, Wenying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418676/
https://www.ncbi.nlm.nih.gov/pubmed/25938778
http://dx.doi.org/10.1371/journal.pone.0126027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418676/
https://www.ncbi.nlm.nih.gov/pubmed/25938778
http://dx.doi.org/10.1371/journal.pone.0126027

Ejemplares similares